BioPharmX Corp. (NYSE: BPMX) Starts Presentation at 30th Annual ROTH Conference
BioPharmX (NYSE: BPMX) is a specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in dermatology, aesthetics and women’s health. BioPharmX aims to bring new products to market by identifying optimal delivery mechanisms and alternative applications for FDA-approved or well characterized active pharmaceutical ingredients (APIs) and biological materials. The Silicon Valley-based company employs a market-driven approach to recognize the restrictions of current treatment options and work to develop products that may address these limitations in areas of efficacy, safety, or patient experience. For more information, visit the company’s website at www.BioPharmX.com.…







